These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34343276)

  • 1. Cardiac allograft vasculopathy: current review and future research directions.
    Pober JS; Chih S; Kobashigawa J; Madsen JC; Tellides G
    Cardiovasc Res; 2021 Nov; 117(13):2624-2638. PubMed ID: 34343276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.
    Amano J; Akashima T; Terasaki T; Wada Y; Ito-Amano M; Suzuki J; Isobe M
    Ann Thorac Cardiovasc Surg; 2015; 21(1):45-52. PubMed ID: 24747545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
    Jansen MA; Otten HG; de Weger RA; Huibers MM
    Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy: a donor or recipient induced pathology?
    van den Hoogen P; Huibers MM; Sluijter JP; de Weger RA
    J Cardiovasc Transl Res; 2015 Mar; 8(2):106-16. PubMed ID: 25652948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.
    Pober JS; Jane-wit D; Qin L; Tellides G
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1609-14. PubMed ID: 24903097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanisms.
    Madsen JC; Sachs DH; Fallon JT; Weissman NJ
    J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1230-9. PubMed ID: 8642825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
    Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
    Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy.
    Glinton K; DeBerge M; Fisher E; Schroth S; Sinha A; Wang JJ; Wasserstrom JA; Ansari MJ; Zhang ZJ; Feinstein M; Leventhal JR; Forbess JM; Lomasney J; Luo X; Thorp EB
    J Heart Lung Transplant; 2021 Jun; 40(6):435-446. PubMed ID: 33846079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity and cardiac allograft rejection.
    Millington TM; Madsen JC
    Kidney Int Suppl; 2010 Dec; (119):S18-21. PubMed ID: 21116311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allograft-induced proliferation of vascular smooth muscle cells: potential targets for treating transplant vasculopathy.
    Autieri MV
    Curr Vasc Pharmacol; 2003 Mar; 1(1):1-9. PubMed ID: 15320847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
    Zhao H; Zhang Y; Song G; Zhao W; Bai X; Zhang J; Zhao X
    Transplant Proc; 2013 Mar; 45(2):635-8. PubMed ID: 23498802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts.
    Libby P; Tanaka H
    Clin Transplant; 1994 Jun; 8(3 Pt 2):313-8. PubMed ID: 7520306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac allograft vasculopathy--the cellular attack.
    Hutchinson IV
    Z Kardiol; 2000; 89 Suppl 9():IX/16-20. PubMed ID: 11151784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human vascular cells decreases their expression of transforming growth factor-beta.
    Lebastchi AH; Qin L; Khan SF; Zhou J; Geirsson A; Kim RW; Li W; Tellides G
    Atherosclerosis; 2011 Dec; 219(2):417-24. PubMed ID: 21862019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of chronic cardiac allograft rejection.
    Costello JP; Mohanakumar T; Nath DS
    Tex Heart Inst J; 2013; 40(4):395-9. PubMed ID: 24082367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy.
    Autieri MV; Kelemen S; Thomas BA; Feller ED; Goldman BI; Eisen HJ
    Circulation; 2002 Oct; 106(17):2218-23. PubMed ID: 12390951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.